ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,174,000 | -1.8% | 12,637 | -37.0% | 0.07% | +6.0% |
| Q3 2021 | $1,195,000 | -28.7% | 20,067 | -18.4% | 0.07% | -25.6% |
| Q2 2021 | $1,677,000 | +19.4% | 24,586 | +21.4% | 0.09% | +12.5% |
| Q1 2021 | $1,405,000 | -8.5% | 20,248 | +1.3% | 0.08% | -27.9% |
| Q4 2020 | $1,535,000 | -64.3% | 19,979 | -65.3% | 0.11% | -20.7% |
| Q3 2020 | $4,301,000 | -39.4% | 57,508 | -49.0% | 0.14% | -23.5% |
| Q2 2020 | $7,101,000 | +113.6% | 112,808 | +42.5% | 0.18% | +108.0% |
| Q1 2020 | $3,325,000 | -49.5% | 79,158 | -45.4% | 0.09% | -4.3% |
| Q4 2019 | $6,584,000 | +490.5% | 144,965 | +494.9% | 0.09% | +607.7% |
| Q3 2019 | $1,115,000 | +20.2% | 24,368 | +54.0% | 0.01% | -27.8% |
| Q2 2019 | $928,000 | +323.7% | 15,826 | +223.7% | 0.02% | +350.0% |
| Q1 2019 | $219,000 | – | 4,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |